Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2022

Employee Benefit and Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Stock Option Activity

Stock option activity was as follows:

(In thousands, except per share amounts)	Number of Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
	(In thousands)			(In dollars)		(In years)		(In thousands)
Outstanding as of December 31, 2021		912		$	30.19
Exercised		(37	)	$	20.16
Expired		(3	)	$	20.57
Outstanding as of December 31, 2022		872		$	30.64		5.37	$	—
As of December 31, 2022
Vested and expected to vest		872		$	30.64		5.37	$	—
Exercisable Options		804		$	30.98		5.27	$	—

Schedule of Ranges of Outstanding And Exercisable Stock Options

The following table summarizes significant ranges of outstanding and exercisable stock options as of December 31, 2022:

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Shares Outstanding		Weighted- Average Remaining Contractual Life		Weighted- Average Exercise Price Per Share		Shares Exercisable		Weighted- Average Exercise Price Per Share
	(In thousands)		(In years)		(In dollars)		(In thousands)		(In dollars)
$18.58 - $25.37		224		3.74	$	24.01		224	$	24.01
$26.61 - $26.61		370		6.55	$	26.61		302	$	26.61
$38.32 - $41.67		278		5.12	$	41.37		278	$	41.37
$18.58 - $41.67		872		5.37	$	30.64		804	$	30.98

Schedule of RSU Activity

RSU activity was as follows:

(In thousands, except per share amounts)	Number of Shares			Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term		Average Intrinsic Value
Outstanding as of December 31, 2021		1,555		$	33.86
Granted		815		$	22.19
Vested		(624	)	$	34.55
Cancelled		(200	)	$	30.87
Outstanding as of December 31, 2022		1,546		$	27.82		1.39	$	27,998

Schedule of Performance Shares Activity

Performance shares were never granted in the years prior to 2020. Performance shares activity was as follows:

(In thousands, except per share amounts)	Number of Shares			Weighted Average Grant Date Fair Value Per Share
	(In thousands)
Outstanding as of December 31, 2019		—			—
Granted		141		$	28.22
Vested		—			—
Cancelled		—			—
Outstanding as of December 31, 2020		141		$	28.22
Granted		152		$	37.58
Vested		—			—
Cancelled		—			—
Outstanding as of December 31, 2021		293		$	33.07
Granted		145			22.37
Vested		—			—
Cancelled		(8	)		27.17
Outstanding as of December 31, 2022		430		$	29.38

Schedule of Weighted Average Assumptions

The following table sets forth the weighted-average assumptions used to estimate the fair value of purchase rights granted under the ESPP:

	Year Ended December 31,
	2022			2021			2020
Expected life (in years)		0.5			0.5			0.5
Risk-free interest rate		2.25	%		0.05	%		0.72	%
Expected volatility		39.6	%		40.8	%		54.8	%
Dividend yield		—			—			—

Schedule of Total Stock-Based Compensation Expense Resulting from Stock Options, RSUs, Performance Shares and the ESPP

The following table sets forth the stock-based compensation expense resulting from stock options, RSUs, performance shares and the ESPP included in the Company’s consolidated statements of operations:

	Year Ended December 31,
(In thousands)	2022		2021		2020
Cost of revenue	$	1,353	$	2,103	$	4,091
Research and development		4,177		5,161		5,183
Sales and marketing		5,603		7,628		7,634
General and administrative		6,601		11,103		13,597
Total	$	17,734	$	25,995	$	30,505